Unexpectedly, in the latter study, the CD73+ ovarian cancer group (mostly including patients with mucinous adenocarcinoma) showed better prognosis and the authors speculated that cell differentiation stage had more influence on the prognosis than the adverse effect of CD73 [59]. The gene discussed is NT5E; the disease is ovarian carcinoma.